vs
CORE MOLDING TECHNOLOGIES INC（CMT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CORE MOLDING TECHNOLOGIES INC的1.0倍（$75.5M vs $74.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 19.5%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-2.9M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -2.2%）
科模成型技术公司1988年成立，总部位于美国俄亥俄州哥伦布市，主要生产片状模塑料以及模压玻纤增强塑料，生产总面积超100万平方英尺，在墨西哥马塔莫罗斯、美国南卡罗来纳州加夫尼、俄亥俄州辛辛那提设有主要分支机构，2011年成立了子公司科瑞特种复合材料有限公司。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CMT vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$74.7M
营收增速更快
PBYI
高出8.2%
19.5%
自由现金流更多
PBYI
多$17.3M
$-2.9M
两年增速更快
PBYI
近两年复合增速
-2.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $74.7M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 15.2% | 69.3% |
| 营业利润率 | 4.8% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 19.5% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.35 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMTPBYI
| Q4 25 | $74.7M | $75.5M | ||
| Q3 25 | $58.4M | $54.5M | ||
| Q2 25 | $79.2M | $52.4M | ||
| Q1 25 | $61.4M | $46.0M | ||
| Q4 24 | $62.5M | $59.1M | ||
| Q3 24 | $73.0M | $80.5M | ||
| Q2 24 | $88.7M | $47.1M | ||
| Q1 24 | $78.1M | $43.8M |
净利润CMTPBYI
| Q4 25 | — | — | ||
| Q3 25 | $1.9M | $8.8M | ||
| Q2 25 | $4.1M | $5.9M | ||
| Q1 25 | $2.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $3.2M | $20.3M | ||
| Q2 24 | $6.4M | $-4.5M | ||
| Q1 24 | $3.8M | $-4.8M |
毛利率CMTPBYI
| Q4 25 | 15.2% | 69.3% | ||
| Q3 25 | 17.4% | 77.7% | ||
| Q2 25 | 18.1% | 76.5% | ||
| Q1 25 | 19.2% | 77.1% | ||
| Q4 24 | 15.8% | 76.4% | ||
| Q3 24 | 16.9% | 63.9% | ||
| Q2 24 | 20.0% | 77.4% | ||
| Q1 24 | 17.0% | 75.5% |
营业利润率CMTPBYI
| Q4 25 | 4.8% | 22.7% | ||
| Q3 25 | 4.4% | 17.6% | ||
| Q2 25 | 6.6% | 12.7% | ||
| Q1 25 | 4.6% | 8.7% | ||
| Q4 24 | 1.4% | 22.6% | ||
| Q3 24 | 4.9% | 27.4% | ||
| Q2 24 | 8.4% | -4.6% | ||
| Q1 24 | 6.1% | -5.3% |
净利率CMTPBYI
| Q4 25 | — | — | ||
| Q3 25 | 3.2% | 16.2% | ||
| Q2 25 | 5.1% | 11.2% | ||
| Q1 25 | 3.6% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.3% | 25.2% | ||
| Q2 24 | 7.2% | -9.6% | ||
| Q1 24 | 4.8% | -11.0% |
每股收益（稀释后）CMTPBYI
| Q4 25 | $0.35 | $0.26 | ||
| Q3 25 | $0.22 | $0.17 | ||
| Q2 25 | $0.47 | $0.12 | ||
| Q1 25 | $0.25 | $0.06 | ||
| Q4 24 | $-0.01 | $0.40 | ||
| Q3 24 | $0.36 | $0.41 | ||
| Q2 24 | $0.73 | $-0.09 | ||
| Q1 24 | $0.43 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $38.1M | $97.5M |
| 总债务越低越好 | $17.6M | $22.7M |
| 股东权益账面价值 | $158.2M | $130.3M |
| 总资产 | $228.1M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.11× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CMTPBYI
| Q4 25 | $38.1M | $97.5M | ||
| Q3 25 | $42.4M | $94.4M | ||
| Q2 25 | $43.2M | $96.0M | ||
| Q1 25 | $44.5M | $93.2M | ||
| Q4 24 | $41.8M | $101.0M | ||
| Q3 24 | $42.3M | $96.7M | ||
| Q2 24 | $37.8M | $96.8M | ||
| Q1 24 | $26.6M | $107.2M |
总债务CMTPBYI
| Q4 25 | $17.6M | $22.7M | ||
| Q3 25 | $18.2M | $34.0M | ||
| Q2 25 | $18.8M | $45.3M | ||
| Q1 25 | $19.2M | $56.7M | ||
| Q4 24 | $19.7M | $68.0M | ||
| Q3 24 | $20.2M | $79.3M | ||
| Q2 24 | $20.6M | $90.7M | ||
| Q1 24 | $21.1M | $102.0M |
股东权益CMTPBYI
| Q4 25 | $158.2M | $130.3M | ||
| Q3 25 | $155.4M | $115.3M | ||
| Q2 25 | $153.5M | $104.7M | ||
| Q1 25 | $149.9M | $97.1M | ||
| Q4 24 | $147.4M | $92.1M | ||
| Q3 24 | $147.8M | $71.1M | ||
| Q2 24 | $147.5M | $48.5M | ||
| Q1 24 | $142.8M | $51.0M |
总资产CMTPBYI
| Q4 25 | $228.1M | $216.3M | ||
| Q3 25 | $219.7M | $202.9M | ||
| Q2 25 | $219.9M | $194.9M | ||
| Q1 25 | $223.6M | $196.2M | ||
| Q4 24 | $209.6M | $213.3M | ||
| Q3 24 | $220.7M | $220.7M | ||
| Q2 24 | $225.7M | $205.0M | ||
| Q1 24 | $212.3M | $214.1M |
负债/权益比CMTPBYI
| Q4 25 | 0.11× | 0.17× | ||
| Q3 25 | 0.12× | 0.30× | ||
| Q2 25 | 0.12× | 0.43× | ||
| Q1 25 | 0.13× | 0.58× | ||
| Q4 24 | 0.13× | 0.74× | ||
| Q3 24 | 0.14× | 1.12× | ||
| Q2 24 | 0.14× | 1.87× | ||
| Q1 24 | 0.15× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.9M | $14.4M |
| 自由现金流率自由现金流/营收 | -3.9% | 19.1% |
| 资本支出强度资本支出/营收 | 10.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CMTPBYI
| Q4 25 | $5.0M | $14.4M | ||
| Q3 25 | $4.6M | $9.7M | ||
| Q2 25 | $3.5M | $14.1M | ||
| Q1 25 | $6.1M | $3.6M | ||
| Q4 24 | $5.0M | $15.6M | ||
| Q3 24 | $9.2M | $11.0M | ||
| Q2 24 | $15.9M | $1.0M | ||
| Q1 24 | $5.1M | $11.2M |
自由现金流CMTPBYI
| Q4 25 | $-2.9M | $14.4M | ||
| Q3 25 | $-346.0K | $9.7M | ||
| Q2 25 | $880.0K | $14.1M | ||
| Q1 25 | $4.3M | $3.6M | ||
| Q4 24 | $509.0K | $15.6M | ||
| Q3 24 | $7.0M | $11.0M | ||
| Q2 24 | $13.0M | $1.0M | ||
| Q1 24 | $3.2M | — |
自由现金流率CMTPBYI
| Q4 25 | -3.9% | 19.1% | ||
| Q3 25 | -0.6% | 17.7% | ||
| Q2 25 | 1.1% | 26.8% | ||
| Q1 25 | 7.0% | 7.7% | ||
| Q4 24 | 0.8% | 26.4% | ||
| Q3 24 | 9.6% | 13.7% | ||
| Q2 24 | 14.6% | 2.1% | ||
| Q1 24 | 4.1% | — |
资本支出强度CMTPBYI
| Q4 25 | 10.7% | 0.0% | ||
| Q3 25 | 8.4% | 0.0% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | 7.2% | 0.0% | ||
| Q3 24 | 3.1% | 0.0% | ||
| Q2 24 | 3.3% | 0.0% | ||
| Q1 24 | 2.4% | 0.0% |
现金转化率CMTPBYI
| Q4 25 | — | — | ||
| Q3 25 | 2.44× | 1.10× | ||
| Q2 25 | 0.86× | 2.41× | ||
| Q1 25 | 2.79× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | 0.54× | ||
| Q2 24 | 2.47× | — | ||
| Q1 24 | 1.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
